Eurofins Core Business Strong Organic Growth Further Accelerates in April
Regulatory News: Eurofins Scientific (Paris:ERF): 4 June 2021 April 2021 has delivered another strong trading performance, continuing the positive trends seen in Q1 and reflecting both the significant contribution from COVID-19 related activities and the rapidly accelerating growth of the Groups Core Business (excluding COVID-19 related clinical testing and reagent revenues).
Eurofins Core Business Strong Organic Growth Further Accelerates in April
Regulatory News: Eurofins Scientific (Paris:ERF): 4 June 2021 April 2021 has delivered another strong trading performance, continuing the positive trends seen in Q1 and reflecting both the significant contribution from COVID-19 related activities and the rapidly accelerating growth of the Groups Core Business (excluding COVID-19 related clinical testing and reagent revenues).